Qube Research & Technologies (QRT)
KURA icon

Qube Research & Technologies (QRT)’s Kura Oncology KURA Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.8M Sell
1,169,884
-466,849
-29% -$4.4M 0.01% 1142
2026
Q1 		$13.3M Buy
1,636,733
+303,210
+23% +$2.6M 0.01% 1115
2025
Q4 		$13.9M Sell
1,333,523
-379,193
-22% -$3.98M 0.01% 1127
2025
Q3 		$15.2M Sell
1,712,716
-199,170
-10% -$1.42M 0.02% 1051
2025
Q2 		$11M Buy
1,911,886
+738,761
+63% +$4.53M 0.01% 1230
2025
Q1 		$7.74M Buy
1,173,125
+57,384
+5% +$447K 0.01% 1283
2024
Q4 		$9.72M Buy
1,115,741
+1,012,672
+983% +$14.6M 0.01% 1106
2024
Q3 		$2.01M Buy
+103,069
New +$2.09M ﹤0.01% 1760
2024
Q2 		– Sell
-35,548
Closed -$758K – 4329
2024
Q1 		$758K Sell
35,548
-53,341
-60% -$1.04M ﹤0.01% 2309
2023
Q4 		$1.28M Buy
+88,889
New +$874K ﹤0.01% 1781
2023
Q3 		– Sell
-43,114
Closed -$456K – 4227
2023
Q2 		$456K Buy
+43,114
New +$510K ﹤0.01% 1533
2023
Q1 		– Sell
-18,887
Closed -$234K – 2812
2022
Q4 		$234K Buy
+18,887
New +$275K ﹤0.01% 1744
2021
Q3 		– Sell
-55,307
Closed -$1.15M – 2516
2021
Q2 		$1.15M Buy
55,307
+43,505
+369% +$1.08M 0.01% 883
2021
Q1 		$334K Buy
11,802
+4,764
+68% +$151K 0.01% 1403
2020
Q4 		$230K Buy
+7,038
New +$247K ﹤0.01% 1480
2020
Q1 		– Sell
-21,297
Closed -$293K – 1421
2019
Q4 		$293K Buy
+21,297
New +$316K 0.01% 1233

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Qube Research & Technologies (QRT)'s KURA Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its Kura Oncology (KURA) stake by 29% in Q2 2026, selling an estimated $4.4M and leaving 1,169,884 shares worth $12.8M. The position accounts for 0.01% of the portfolio, ranked #1142.

Qube Research & Technologies (QRT) first reported a position in KURA in Q4 2019 and has held it in 16 quarters since. The position peaked at $15.2M in Q3 2025. 220 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Qube Research & Technologies (QRT) held 1,169,884 shares of Kura Oncology worth $12.8M as of Q2 2026.
  • Qube Research & Technologies (QRT) sold 466,849 Kura Oncology shares in Q2 2026, an estimated $4.4M.
  • Kura Oncology made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1142 holding.
  • Qube Research & Technologies (QRT) first reported a position in Kura Oncology in Q4 2019 and has held it in 16 quarters since.
  • Qube Research & Technologies (QRT)'s Kura Oncology position peaked at $15.2M in Q3 2025.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.